Regulation of the intracellular localization of Foxo3a by stress-activated protein kinase signaling pathways in skeletal muscle cells

Molecular and Cellular Biology

Volumn 30, Issue 2, 2010, Pages 470-480

  Clavel, Stephan ^a   Siffroi Fernandez, Sandrine ^a   Coldefy, Anne Sophie ^a,b   Boulukos, Kim ^a   Pisani, Didier F ^a   Dérijard, Benoît ^a  

^a UNIVERSITÉ CÔTE D'AZUR   (France)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATROGIN 1; EXPORTIN 1; MITOGEN ACTIVATED PROTEIN KINASE KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE KINASE 4; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEASOME; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR FKHRL1;

ANIMAL CELL; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; MOUSE; MUSCLE ATROPHY; MUSCLE CELL; MYOTUBE; NONHUMAN; NUCLEAR EXPORT SIGNAL; NUCLEAR IMPORT; NUCLEOCYTOPLASMIC TRANSPORT; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; TRANSCRIPTION REGULATION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; ANTHRACENES; CELL LINE; CELL NUCLEUS; CHROMONES; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; ISOQUINOLINES; KARYOPHERINS; MAP KINASE KINASE 3; MAP KINASE KINASE 4; MICE; MITOGEN-ACTIVATED PROTEIN KINASE KINASES; MORPHOLINES; MUSCLE CELLS; MUSCLE FIBERS, SKELETAL; MUSCLE PROTEINS; MUSCULAR ATROPHY; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE INHIBITORS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTORS, CYTOPLASMIC AND NUCLEAR; SIGNAL TRANSDUCTION; SKP CULLIN F-BOX PROTEIN LIGASES; SULFONAMIDES; THIOPHENES; TRANSFECTION;

EID: 73549122141     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.00666-09     Document Type: Article

References (51)

1. Arden, K. C. 2008. FOXO animal models reveal a variety of diverse roles for FOXO transcription factors. Oncogene 27:2345-2350.
2. Asada, S., H. Daitoku, H. Matsuzaki, T. Saito, T. Sudo, H. Mukai, S. Iwashita, K. Kako, T. Kishi, Y. Kasuya, and A. Fukamizu. 2007. Mitogen-activated protein kinases, Erk and p38, phosphorylate and regulate Foxo1. Cell. Signal. 19:519-527.
3. Bodine, S. C., E. Latres, S. Baumhueter, V. K. Lai, L. Nunez, B. A. Clarke, W. T. Poueymirou, F. J. Panaro, E. Na, K. Dharmarajan, Z. Q. Pan, D. M. Valenzuela, T. M. DeChiara, T. N. Stitt, G. D. Yancopoulos, and D. J. Glass. 2001. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294:1704-1708.
4. Bois, P. R., V. F. Brochard, A. V. Salin-Cantegrel, J. L. Cleveland, and G. C. Grosveld. 2005. FoxO1a-cyclic GMP-dependent kinase I interactions orchestrate myoblast fusion. Mol. Cell. Biol. 25:7645-7656.
5. Brunet, A., A. Bonni, M. J. Zigmond, M. Z. Lin, P. Juo, L. S. Hu, M. J. Anderson, K. C. Arden, J. Blenis, and M. E. Greenberg. 1999. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell 96:857-868.
6. Brunet, A., J. Park, H. Tran, L. S. Hu, B. A. Hemmings, and M. E. Greenberg. 2001. Protein kinase SGK mediates survival signals by phosphorylating the forkhead transcription factor FKHRL1 (FOXO3a). Mol. Cell. Biol. 21:952-965.
7. Brunet, A., L. B. Sweeney, J. F. Sturgill, K. F. Chua, P. L. Greer, Y. Lin, H. Tran, S. E. Ross, R. Mostoslavsky, H. Y. Cohen, L. S. Hu, H. L. Cheng, M. P. Jedrychowski, S. P. Gygi, D. A. Sinclair, F. W. Alt, and M. E. Greenberg. 2004. Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science 303:2011-2015.
8. Burgering, B. M., and P. J. Coffer. 1995. Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction. Nature 376:599-602.
9. Cabane, C., A. S. Coldefy, K. Yeow, and B. Derijard. 2004. The p38 pathway regulates Akt both at the protein and transcriptional activation levels during myogenesis. Cell. Signal. 16:1405-1415.
10. Cabane, C., W. Englaro, K. Yeow, M. Ragno, and B. Derijard. 2003. Regulation of C2C12 myogenic terminal differentiation by MKK3/p38alpha pathway. Am. J. Physiol. Cell Physiol. 284:C658-C666.
11. Cai, D., J. D. Frantz, N. E. Tawa, Jr., P. A. Melendez, B. C. Oh, H. G. Lidov, P. O. Hasselgren, W. R. Frontera, J. Lee, D. J. Glass, and S. E. Shoelson. 2004. IKKbeta/NF-kappaB activation causes severe muscle wasting in mice. Cell 119:285-298.
12. Calnan, D. R., and A. Brunet. 2008. The FoxO code. Oncogene 27:2276-2288.
13. Cao, P. R., H. J. Kim, and S. H. Lecker. 2005. Ubiquitin-protein ligases in muscle wasting. Int. J. Biochem. Cell Biol. 37:2088-2097.
14. Charvet, C., I. Alberti, F. Luciano, A. Jacquel, A. Bernard, P. Auberger, and M. Deckert. 2003. Proteolytic regulation of Forkhead transcription factor FOXO3a by caspase-3-like proteases. Oncogene 22:4557-4568.
15. Chiacchiera, F., A. Matrone, E. Ferrari, G. Ingravallo, G. Lo Sasso, S. Murzilli, M. Petruzzelli, L. Salvatore, A. Moschetta, and C. Simone. 2009. p38alpha blockade inhibits colorectal cancer growth in vivo by inducing a switch from HIF1alpha- to FoxO-dependent transcription. Cell Death Differ. 16:1203-1214.
16. Clavel, S., A. S. Coldefy, E. Kurkdjian, J. Salles, I. Margaritis, and B. Derijard. 2006. Atrophy-related ubiquitin ligases, atrogin-1 and MuRF1 are up-regulated in aged rat tibialis anterior muscle. Mech. Ageing Dev. 127:794-801.
17. Davies, S. P., H. Reddy, M. Caivano, and P. Cohen. 2000. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochem. J. 351:95-105.
18. Dérijard, B., M. Hibi, I. H. Wu, T. Barrett, B. Su, T. Deng, M. Karin, and R. J. Davis. 1994. JNK1: a protein kinase stimulated by UV light and Ha-Ras that binds and phosphorylates the c-Jun activation domain. Cell 76:1025-1037.
19. Dérijard, B., J. Raingeaud, T. Barrett, I. H. Wu, J. Han, R. J. Ulevitch, and R. J. Davis. 1995. Independent human MAP-kinase signal transduction pathways defined by MEK and MKK isoforms. Science 267:682-685.
20. Essers, M. A., S. Weijzen, A. M. de Vries-Smits, I. Saarloos, N. D. de Ruiter, J. L. Bos, and B. M. Burgering. 2004. FOXO transcription factor activation by oxidative stress mediated by the small GTPase Ral and JNK. EMBO J. 23:4802-4812.
21. Greer, E. L., P. R. Oskoui, M. R. Banko, J. M. Maniar, M. P. Gygi, S. P. Gygi, and A. Brunet. 2007. The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor. J. Biol. Chem. 282:30107-30119.
22. Gross, D. N., A. P. van den Heuvel, and M. J. Birnbaum. 2008. The role of FoxO in the regulation of metabolism. Oncogene 27:2320-2336.
23. Guo, J., Z. Gertsberg, N. Ozgen, and S. F. Steinberg. 2009. p66Shc links alpha1-adrenergic receptors to a reactive oxygen species-dependent AKT-FOXO3A phosphorylation pathway in cardiomyocytes. Circ. Res. 104:660-669.
24. Han, J., J. D. Lee, L. Bibbs, and R. J. Ulevitch. 1994. A MAP kinase targeted by endotoxin and hyperosmolarity in mammalian cells. Science 265:808-811.
25. Hazzalin, C. A., R. Le Panse, E. Cano, and L. C. Mahadevan. 1998. Anisomycin selectively desensitizes signalling components involved in stress kinase activation and fos and jun induction. Mol. Cell. Biol. 18:1844-1854.
26. Hu, M. C., D. F. Lee, W. Xia, L. S. Golfman, F. Ou-Yang, J. Y. Yang, Y. Zou, S. Bao, N. Hanada, H. Saso, R. Kobayashi, and M. C. Hung. 2004. IkappaB kinase promotes tumorigenesis through inhibition of forkhead FOXO3a. Cell 117:225-237.
27. Jagoe, R. T., and A. L. Goldberg. 2001. What do we really know about the ubiquitin-proteasome pathway in muscle atrophy? Curr. Opin. Clin. Nutr. Metab. Care 4:183-190.
28. Keren, A., Y. Tamir, and E. Bengal. 2006. The p38 MAPK signaling pathway: a major regulator of skeletal muscle development. Mol. Cell. Endocrinol. 252:224-230.
29. Kishore, N., C. Sommers, S. Mathialagan, J. Guzova, M. Yao, S. Hauser, K. Huynh, S. Bonar, C. Mielke, L. Albee, R. Weier, M. Graneto, C. Hanau, T. Perry, and C. S. Tripp. 2003. A selective IKK-2 inhibitor blocks NF-kappa B-dependent gene expression in interleukin-1 beta-stimulated synovial fibroblasts. J. Biol. Chem. 278:32861-32871.
30. Kudo, N., N. Matsumori, H. Taoka, D. Fujiwara, E. P. Schreiner, B. Wolff, M. Yoshida, and S. Horinouchi. 1999. Leptomycin B inactivates CRM1/ exportin 1 by covalent modification at a cysteine residue in the central conserved region. Proc. Natl. Acad. Sci. U. S. A. 96:9112-9117.
31. Leong, M. L., A. C. Maiyar, B. Kim, B. A. O'Keeffe, and G. L. Firestone. 2003. Expression of the serum- and glucocorticoid-inducible protein kinase, Sgk, is a cell survival response to multiple types of environmental stress stimuli in mammary epithelial cells. J. Biol. Chem. 278:5871-5882.
32. Li, Y. P., Y. Chen, J. John, J. Moylan, B. Jin, D. L. Mann, and M. B. Reid. 2005. TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle. FASEB J. 19:362-370.
33. Lluís, F., E. Perdiguero, A. R. Nebreda, and P. Munoz-Canoves. 2006. Regulation of skeletal muscle gene expression by p38 MAP kinases. Trends Cell Biol. 16:36-44.
34. Mammucari, C., S. Schiaffino, and M. Sandri. 2008. Downstream of Akt: FoxO3 and mTOR in the regulation of autophagy in skeletal muscle. Autophagy 4:524-526.
35. Martin, P., O. Albagli, M. C. Poggi, K. E. Boulukos, and P. Pognonec. 2006. Development of a new bicistronic retroviral vector with strong IRES activity. BMC Biotechnol. 6:4.
36. McClung, J. M., A. R. Judge, E. E. Talbert, and S. K. Powers. 2009. Calpain-1 is required for hydrogen peroxide-induced myotube atrophy. Am. J. Physiol. Cell Physiol. 296:C363-C371.
37. Mograbi, B., R. Bocciardi, I. Bourget, R. Busca, N. Rochet, D. Farahi-Far, T. Juhel, and B. Rossi. 2001. Glial cell line-derived neurotrophic factor-stimulated phosphatidylinositol 3-kinase and Akt activities exert opposing effects on the ERK pathway: importance for the rescue of neuroectodermic cells. J. Biol. Chem. 276:45307-45319.
38. Moylan, J. S., and M. B. Reid. 2007. Oxidative stress, chronic disease, and muscle wasting. Muscle Nerve 35:411-429.
39. Nemoto, S., and T. Finkel. 2002. Redox regulation of forkhead proteins through a p66shc-dependent signaling pathway. Science 295:2450-2452.
40. Nury, D., C. Doucet, and O. Coux. 2007. Roles and potential therapeutic targets of the ubiquitin proteasome system in muscle wasting. BMC Biochem. 8(Suppl. 1):S7.
41. Oh, S. W., A. Mukhopadhyay, N. Svrzikapa, F. Jiang, R. J. Davis, and H. A. Tissenbaum. 2005. JNK regulates lifespan in Caenorhabditis elegans by modulating nuclear translocation of forkhead transcription factor/DAF-16. Proc. Natl. Acad. Sci. U. S. A. 102:4494-4499.
42. Raman, M., W. Chen, and M. H. Cobb. 2007. Differential regulation and properties of MAPKs. Oncogene 26:3100-3112.
43. Salih, D. A., and A. Brunet. 2008. FoxO transcription factors in the maintenance of cellular homeostasis during aging. Curr. Opin. Cell Biol. 20:126-136.
44. Sandri, M., C. Sandri, A. Gilbert, C. Skurk, E. Calabria, A. Picard, K. Walsh, S. Schiaffino, S. H. Lecker, and A. L. Goldberg. 2004. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117:399-412.
45. Schultze, N., Y. Burki, Y. Lang, U. Certa, and H. Bluethmann. 1996. Efficient control of gene expression by single step integration of the tetracycline system in transgenic mice. Nat. Biotechnol. 14:499-503.
46. Sluss, H. K., T. Barrett, B. Derijard, and R. J. Davis. 1994. Signal transduction by tumor necrosis factor mediated by JNK protein kinases. Mol. Cell. Biol. 14:8376-8384.
47. Sunayama, J., F. Tsuruta, N. Masuyama, and Y. Gotoh. 2005. JNK antagonizes Akt-mediated survival signals by phosphorylating 14-3-3. J. Cell Biol. 170:295-304.
48. van der Horst, A., and B. M. Burgering. 2007. Stressing the role of FoxO proteins in lifespan and disease. Nat. Rev. Mol. Cell Biol. 8:440-450.
49. Wang, M. C., D. Bohmann, and H. Jasper. 2005. JNK extends life span and limits growth by antagonizing cellular and organism-wide responses to insulin signaling. Cell 121:115-125.
50. Wang, M. C., D. Bohmann, and H. Jasper. 2003. JNK signaling confers tolerance to oxidative stress and extends lifespan in Drosophila. Dev. Cell 5:811-816.
51. Zhao, J., J. J. Brault, A. Schild, P. Cao, M. Sandri, S. Schiaffino, S. H. Lecker, and A. L. Goldberg. 2007. FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab. 6:472-483.